Pleural effusion: nursing assessment, interventions, and thoracentesis care

LS
By Lindsay Smith, AGPCNP
Updated March 26, 2026

A pleural effusion is an abnormal accumulation of fluid in the pleural space — the cavity between the visceral and parietal pleura surrounding the lung. Under normal conditions, only 10–20 mL of fluid occupies this space, providing lubrication during breathing. When fluid accumulates beyond this, it compresses lung tissue, impairs ventilation, and causes dyspnea. Pleural effusions are common across medical, surgical, cardiac, and oncology settings, making them essential knowledge for nursing students at every level.

The two fundamental categories — transudative and exudative — have different causes, different diagnostic findings, and different management pathways. Correctly distinguishing them guides everything from which labs to collect to which treatment the physician will order. This reference covers pathophysiology, causes by type, diagnostic workup including Light’s criteria, nursing assessment, thoracentesis care, and NCLEX-style practice questions.

Pair this page with the pneumonia nursing reference, pulmonary embolism nursing reference, and ARDS nursing reference — pleural effusions frequently co-occur with all three.

Quick referenceDetail
DefinitionAbnormal fluid accumulation in the pleural space; normal volume is 10–20 mL
Two main typesTransudative (pressure-related) vs. exudative (inflammatory/protein-rich)
Most common cause (transudate)Congestive heart failure (~40% of all pleural effusions)
Most common cause (exudate)Pneumonia (parapneumonic effusion)
Classification toolLight's criteria — applied to pleural fluid from thoracentesis
CXR detection thresholdApproximately 200–300 mL — blunts the costophrenic angle on PA view
Thoracentesis volume limitMaximum 1,500 mL per session — risk of reexpansion pulmonary edema beyond this
Post-thoracentesis priorityMonitor for pneumothorax — CXR within 1–4 hours post-procedure is standard
Key NCLEX conceptPosition patient leaning forward over bedside table during thoracentesis

Pathophysiology

The pleural space is a potential space — normally only a thin film of fluid exists between the two pleural layers. Fluid enters via capillary filtration from the parietal pleural vessels and drains through lymphatic channels. Pleural effusion occurs when this balance is disrupted by one of two mechanisms.

Increased hydrostatic pressure or decreased oncotic pressure drives fluid out of the capillaries and into the pleural space without inflammation or protein leak. The resulting fluid has low protein content — it is essentially an ultrafiltrate of plasma. This is a transudative effusion. Conditions that raise venous hydrostatic pressure (such as heart failure) or reduce plasma oncotic pressure (such as hypoalbuminemia in cirrhosis or nephrotic syndrome) produce transudates.

Inflammation, infection, or disruption of the pleural surface increases capillary permeability, allowing protein, cells, and cellular debris to leak into the pleural space. The resulting fluid is protein-rich and cellular — an exudative effusion. Pneumonia, malignancy, tuberculosis, and pulmonary embolism all produce exudates through this mechanism.

This distinction is clinically essential because transudates are managed by treating the underlying hemodynamic problem (e.g., diuresis in heart failure), while exudates require specific treatment targeting the inflammatory cause (e.g., antibiotics for parapneumonic effusion, oncologic treatment for malignant effusion).


Etiology

TypeMechanismCommon causes
TransudativePressure/oncotic imbalance — low protein leakCongestive heart failure (most common overall), hepatic cirrhosis, hypoalbuminemia, nephrotic syndrome, peritoneal dialysis, atelectasis
ExudativeInflammation/permeability — protein-richParapneumonic effusion (pneumonia), malignancy (lung, breast, lymphoma), tuberculosis, pulmonary embolism, pancreatitis, rheumatoid arthritis, lupus, hemothorax, chylothorax

Key distinctions to know for NCLEX:

  • Congestive heart failure is the single most common cause of pleural effusion overall. It typically produces bilateral effusions, often larger on the right. The mechanism is elevated pulmonary venous and hydrostatic pressure — classic transudate.
  • Parapneumonic effusion develops in approximately 40% of bacterial pneumonias. Uncomplicated parapneumonic effusions resolve with antibiotics; complicated effusions (low pH, low glucose, positive culture) require chest tube drainage.
  • Malignant effusion is an exudate caused by tumor involvement of the pleural surface, lymphatic obstruction, or direct tumor secretion. Common malignancies: lung cancer, breast cancer, and lymphoma. Recurrent malignant effusions are managed with tunneled pleural catheters or pleurodesis.
  • Pulmonary embolism produces an exudative effusion in up to 40% of cases — often small and unilateral. The mechanism involves pleural ischemia from impaired perfusion and inflammatory mediator release. See the pulmonary embolism nursing reference for full PE management.
  • Hepatic cirrhosis produces a hepatic hydrothorax via movement of ascitic fluid through diaphragmatic defects into the pleural space (usually right-sided). It is a transudate.

Clinical presentation

Small effusions (under 300 mL) are often asymptomatic and detected incidentally on imaging. As fluid volume increases, symptoms become apparent.

Respiratory symptoms:

  • Dyspnea — the most common presenting symptom; ranges from exertional dyspnea to dyspnea at rest depending on volume and rate of accumulation
  • Pleuritic chest pain — sharp, localized, worsens with inspiration and coughing; typically present in the early inflammatory phase but often subsides once fluid accumulates and separates the inflamed pleural surfaces
  • Non-productive cough — from compression of adjacent lung parenchyma
  • Orthopnea — may occur with large bilateral effusions

Physical examination findings:

  • Decreased or absent breath sounds over the affected area — hallmark finding; fluid dampens transmission of breath sounds to the chest wall
  • Dullness to percussion — fluid is dense compared to air-filled lung; percussion over an effusion produces a dull (not resonant) note
  • Decreased tactile fremitus — vibration transmitted through the chest wall is reduced when fluid is between the lung and the chest wall
  • Egophony — “E to A” change at the upper border of the effusion; where the compressed lung lies above the fluid, a spoken “E” sounds like “A” on auscultation
  • Tracheal deviation — may be present with massive effusions, deviating toward the unaffected side
  • Decreased chest expansion — on the affected side

Diagnostic workup

Chest X-ray

The standard chest X-ray (PA view) is typically the first imaging obtained. Key findings:

  • Blunting of the costophrenic angle — the earliest finding, visible when approximately 200–300 mL of fluid has accumulated. The normally sharp angle between the diaphragm and chest wall becomes blunted
  • Meniscus sign — the classic concave upper border of a pleural effusion, curving upward toward the lateral chest wall
  • Opacification — larger effusions produce increasing opacification (white-out) of the lower lung field
  • Tracheal deviation — away from the effusion in very large effusions

On a lateral X-ray, smaller volumes (150–200 mL) can blunt the posterior costophrenic angle before the lateral angle is affected.

Limitations: Supine CXR (common in ICU patients) shows effusions as a diffuse haziness over the entire hemithorax rather than a discrete collection — making them easy to miss or confuse with infiltrates.

CT chest

CT scan is more sensitive than plain CXR and can detect effusions as small as 5–10 mL. CT also characterizes the pleural space (loculations, pleural thickening, pleural masses) and the underlying lung, which guides the decision about whether thoracentesis is needed and whether image guidance is required.

Ultrasound

Bedside thoracic ultrasound is the preferred guidance modality for thoracentesis. It improves needle placement accuracy and significantly reduces the risk of pneumothorax compared to landmark-based thoracentesis. Ultrasound can detect effusions as small as 20 mL.

Thoracentesis and pleural fluid analysis

Thoracentesis — needle aspiration of pleural fluid — is the definitive diagnostic procedure. Fluid is sent for a standard panel of tests:

TestWhat it tells youKey values
ProteinDifferentiates exudate from transudate (via Light's criteria)See Light's criteria table below
LDHMarker of inflammation/tissue breakdown; also used in Light's criteriaElevated in exudates
GlucoseLow glucose (<60 mg/dL) suggests complicated parapneumonic, TB, malignancy, or rheumatoidNormal: similar to serum glucose
pHLow pH (<7.20) in complicated parapneumonic effusion or empyema — indicates need for chest tube drainageNormal pleural fluid: ~7.60
Cell count and differentialPredominant cell type guides diagnosis: neutrophils (acute infection), lymphocytes (TB, malignancy), eosinophils (air/blood in space)
Culture and Gram stainIdentifies organism in infected effusion/empyemaPositive in empyema
CytologyDetects malignant cellsPositive in ~60% of malignant effusions (one tap)
TriglyceridesElevated (>110 mg/dL) in chylothorax (lymphatic disruption)

Light’s criteria

Light’s criteria, first described by Dr. Richard Light in 1972, remain the clinical standard for distinguishing transudative from exudative effusions. The criteria require simultaneous serum and pleural fluid samples.

An effusion is exudative if it meets ANY ONE of the following:

Light's criterionExudate thresholdWhat it measures
Pleural fluid protein / serum protein ratio> 0.5Protein leak from inflamed or permeable pleura
Pleural fluid LDH / serum LDH ratio> 0.6Inflammatory enzyme activity relative to serum
Pleural fluid LDH (absolute)> 2/3 of the upper limit of normal serum LDHAbsolute marker of cellular breakdown in pleural space

If none of the three criteria are met, the effusion is classified as a transudate.

Clinical pearl — the misclassification problem: Light’s criteria have a sensitivity for exudates of approximately 98%, but specificity is only around 72–83%. This means some true transudates (particularly in heart failure patients treated with diuretics) will be misclassified as exudates. When clinical suspicion for CHF is high but the fluid meets exudate criteria by a narrow margin, the serum-to-pleural fluid albumin gradient (>1.2 g/dL suggests transudate) can be used as a corrective step. This is a known limitation frequently tested on licensing exams.


Nursing assessment

Respiratory assessment priorities

  • Breath sounds: Auscultate all lung fields bilaterally. Document decreased or absent sounds over the affected area and the level at which sounds diminish. Reassess after any intervention.
  • Respiratory rate and effort: Note rate, depth, accessory muscle use, nasal flaring, subcostal retractions, and pursed-lip breathing
  • Oxygen saturation: Continuous SpO2 monitoring; report sustained SpO2 below 94% (or per provider parameters) and any acute drops
  • Percussion: Assess for dullness over the lower lung fields on the affected side
  • Chest symmetry and expansion: Compare bilateral expansion; decreased expansion on the affected side
  • Cough: Frequency and character (productive vs. non-productive)

Comfort assessment

  • Pain: Use a validated pain scale; characterize quality (sharp, pleuritic vs. dull, pressure), location, and whether it changes with position or breathing
  • Position of comfort: Many patients with pleural effusion prefer sitting upright or leaning slightly forward — this maximizes use of the unaffected lung and reduces dyspnea
  • Activity tolerance: Note when dyspnea begins with exertion; use for goal-setting and discharge planning

Hemodynamic and systemic assessment

  • Vital signs including temperature (fever suggests infectious etiology)
  • Peripheral edema, jugular venous distension, and S3 gallop (suggest CHF as underlying cause)
  • Liver enlargement or ascites (suggest hepatic cirrhosis)
  • Weight (daily weights help track fluid status in cardiac and hepatic patients)

Nursing interventions

InterventionRationaleKey points
Positioning — affected side downImproves V/Q matching in the healthy lung by placing it in the dependent position, maximizing perfusion to ventilated lung unitsCounter-intuitive but evidence-based; unaffected lung receives better perfusion when dependent
Head of bed elevationReduces pressure on diaphragm from abdominal contents; improves tidal volumeTarget 30–45° for dyspneic patients; higher angle (chair position) may provide more relief
Supplemental oxygenCorrect hypoxemia from V/Q mismatchTitrate to maintain SpO2 per provider target; avoid routine high-flow O2 in COPD patients
Pain managementPleuritic pain inhibits deep breathing, increasing atelectasis riskNon-steroidal anti-inflammatory drugs (NSAIDs) are first-line for pleuritic pain; opioids may suppress respiration — use cautiously
Fluid management monitoringDiuretics treat transudative effusions from CHF or cirrhosisMonitor daily weights, I&O, electrolytes; report urine output <0.5 mL/kg/hr
Pre/post-thoracentesis careReduce procedure complications and detect pneumothorax earlySee thoracentesis section below
Incentive spirometryMaintain airway patency and prevent atelectasis in the compressed lungEncourage every 1–2 hours while awake
Patient educationPromotes self-monitoring and adherence to treatment of underlying causeTeach dyspnea warning signs, when to call the provider, daily weight monitoring for CHF patients

Positioning rationale (information gain)

The recommendation to position the patient with the affected side down is a frequently misunderstood intervention. Students often assume the unaffected (healthy) lung should be down — but the reasoning is the opposite. When the affected side is dependent, the healthy lung moves to the superior (non-dependent) position. Gravity directs blood flow preferentially to the dependent (affected) lung, but because that lung is compressed by fluid, the V/Q mismatch worsens. Positioning the affected lung dependent allows the healthy lung to receive better ventilation while perfusion is preferentially distributed to where the lung can participate in gas exchange. This is the same mechanism behind prone positioning in ARDS — redirecting blood flow toward better-ventilated lung units.


Thoracentesis nursing care

Thoracentesis is the procedure most directly managed by bedside nursing. It involves insertion of a needle or catheter through the chest wall into the pleural space to drain fluid.

Pre-procedure preparation

  1. Informed consent — confirm signed consent is obtained; reinforce patient education on the procedure, positioning, and expected sensations
  2. Positioning — the standard position is the patient sitting upright on the edge of the bed, leaning forward over a bedside table with arms resting on a pillow. This position widens the intercostal spaces posteriorly, opens the pleural space, and drops the diaphragm — maximizing access for the physician or proceduralist. Alternatively, the patient may straddle the chair backward and lean forward on a pillow resting on the chair back
  3. Baseline vital signs — document respiratory rate, SpO2, blood pressure, and heart rate before the procedure
  4. IV access — confirm patent IV access in case of emergent medications
  5. Ultrasound marking — coordinate with provider for real-time or marked ultrasound guidance
  6. Labs — confirm coagulation studies (INR, platelet count) are available if ordered; thoracentesis carries bleeding risk if coagulopathy is present
  7. Explain what to expect — the patient will feel pressure and possibly a brief sharp sensation when local anesthetic is injected; instruct them not to cough or move during needle insertion

During the procedure

  • Maintain the patient in the correct position throughout; steady patients who may shift
  • Monitor SpO2 and respiratory status continuously
  • Observe for signs of vasovagal reaction (bradycardia, diaphoresis, pallor, hypotension) — common in anxious or older patients
  • Note the color and character of fluid being drained (straw-yellow = typical; bloody = hemothorax or malignancy; cloudy/purulent = empyema; milky = chylothorax)
  • Monitor volume drained — do not exceed 1,500 mL per session to prevent reexpansion pulmonary edema

Post-procedure monitoring

Post-thoracentesis nursing monitoring is a high-yield area for NCLEX and clinical practice.

Pneumothorax is the most significant complication (occurs in approximately 4–8% of thoracenteses without ultrasound guidance; lower with ultrasound). Pneumothorax results from inadvertent puncture of the lung parenchyma or air entry through the catheter.

Signs to monitor for:

  • Sudden onset or worsening dyspnea
  • Ipsilateral sharp chest pain
  • Decreased or absent breath sounds on the affected side (now absent where they were present before)
  • Falling SpO2
  • Tracheal deviation (in tension pneumothorax — a medical emergency)

Post-procedure protocol:

  • Vital signs and SpO2 every 15 minutes for the first hour, then per protocol
  • Chest X-ray within 1–4 hours post-procedure to rule out pneumothorax — this is the standard of care
  • Assess breath sounds bilaterally and compare to pre-procedure baseline
  • Instruct the patient to report any sudden worsening of breathing, chest pain, or lightheadedness

Other complications to monitor:

  • Reexpansion pulmonary edema — can occur if more than 1,500 mL is drained rapidly or if a lung that has been collapsed for weeks reexpands abruptly. Presents as cough, dyspnea, hypoxemia, and frothy sputum after drainage. Report immediately.
  • Bleeding / hemothorax — significant bleeding is uncommon with ultrasound guidance; monitor for increasing chest pain and hemodynamic instability
  • Site infection — monitor the puncture site for erythema, warmth, drainage; reinforce sterile dressing care
  • Vasovagal reaction — during or immediately after the procedure; manage with positioning (supine) and monitor for resolution

Medications

Treatment targets the underlying cause:

  • Diuretics (furosemide, spironolactone): First-line for transudative effusions from CHF or cirrhosis. Reduce systemic fluid overload and venous hydrostatic pressure. Monitor potassium and renal function. See the heart failure nursing reference for full diuretic management details.
  • Antibiotics: For parapneumonic effusions from bacterial pneumonia. Uncomplicated parapneumonic effusions resolve with antibiotic treatment alone. Complicated effusions (pH <7.20, positive culture, loculated) require chest tube drainage in addition to antibiotics. See the pneumonia nursing reference for antibiotic selection.
  • Anticoagulation: For effusions secondary to pulmonary embolism — treatment of the PE typically resolves the effusion. See the pulmonary embolism nursing reference for anticoagulation protocols.
  • Talc pleurodesis: Used for recurrent malignant effusions. Talc is introduced into the pleural space (via chest tube or thoracoscopy) and causes an inflammatory reaction that fuses the pleural layers, obliterating the space and preventing re-accumulation. Patients experience significant pleuritic chest pain for 24–48 hours post-pleurodesis — pain management is a key nursing priority.
  • Tunneled pleural catheters (TPC): An alternative to pleurodesis for malignant effusions. A small catheter is placed percutaneously and remains in situ for intermittent drainage at home. Nursing teaches patients and caregivers how to drain the catheter every 1–3 days.

NCLEX-style practice questions

Question 1

A nurse is assessing a patient admitted with dyspnea and right-sided chest pain. Auscultation reveals decreased breath sounds at the right base with dullness to percussion. Which diagnostic finding would be most consistent with a pleural effusion?

A) Hyperresonance on percussion of the right lower chest B) Blunting of the right costophrenic angle on chest X-ray C) Bilateral wheezing on auscultation D) Increased tactile fremitus over the right lower lobe

Answer: B — blunting of the right costophrenic angle

Rationale: Blunting of the costophrenic angle on CXR is the classic radiographic sign of pleural effusion, visible when approximately 200–300 mL of fluid has accumulated. Percussion produces dullness (not hyperresonance — option A) over fluid. Bilateral wheezing suggests airway obstruction, not pleural fluid. Tactile fremitus is decreased (not increased) when fluid lies between the lung and chest wall, dampening vibration transmission.


Question 2

A pleural fluid sample is sent to the lab after thoracentesis. The results show: pleural fluid protein 4.8 g/dL, serum protein 7.0 g/dL, pleural fluid LDH 280 units/L, serum LDH 320 units/L. Applying Light’s criteria, how should this effusion be classified?

A) Transudative — none of the criteria are met B) Exudative — the protein ratio meets criteria C) Exudative — the LDH ratio meets criteria D) Both B and C — two criteria are met

Answer: D — both protein ratio and LDH ratio criteria are met

Rationale: Light’s criterion 1: pleural:serum protein ratio = 4.8 ÷ 7.0 = 0.69 → exceeds the 0.5 threshold (exudate). Light’s criterion 2: pleural:serum LDH ratio = 280 ÷ 320 = 0.875 → exceeds the 0.6 threshold (exudate). An effusion is classified as exudative if ANY ONE criterion is met — in this case, two criteria are met. Only one criterion needs to be met to classify as exudative.


Question 3

A patient with congestive heart failure is found to have a bilateral pleural effusion. The nurse understands that this effusion is most likely which type, and what is the expected management?

A) Exudative; requires thoracentesis and antibiotics B) Transudative; will likely respond to diuretic therapy C) Exudative; requires talc pleurodesis D) Transudative; requires chest tube drainage

Answer: B — transudative; will likely respond to diuretic therapy

Rationale: CHF is the most common cause of transudative pleural effusion, driven by elevated pulmonary venous hydrostatic pressure. Transudates have low protein content and respond to treatment of the underlying hemodynamic cause — diuresis reduces venous pressure and allows fluid to be reabsorbed. Thoracentesis and chest tubes are reserved for symptomatic relief or complicated effusions. Talc pleurodesis is used for recurrent malignant effusions.


Question 4

A physician is preparing to perform a thoracentesis on a patient with a right-sided pleural effusion. What is the nurse’s most important action regarding patient positioning?

A) Place the patient in the left lateral decubitus position B) Position the patient supine with the right arm raised C) Sit the patient upright, leaning forward over a bedside table with arms supported D) Place the patient in the high-Fowler position with the right side elevated

Answer: C — seated upright, leaning forward over a bedside table

Rationale: The standard thoracentesis position is sitting upright with the patient leaning forward over a padded bedside table. This position widens the posterior intercostal spaces, drops the diaphragm, and opens the pleural space — maximizing access for needle insertion. The lateral decubitus position (A) is occasionally used for patients unable to sit, but the seated forward-leaning position is standard. Supine or high-Fowler positions do not adequately open the posterior pleural space.


Question 5

A thoracentesis has just been completed and 1,200 mL of straw-colored fluid was drained from a patient’s left pleural space. Thirty minutes later the patient develops sudden dyspnea, decreased breath sounds on the left, and a falling SpO2. What is the nurse’s priority action?

A) Administer a bronchodilator for bronchospasm B) Notify the provider immediately — pneumothorax is suspected C) Position the patient on the right side to drain remaining fluid D) Increase supplemental oxygen and document the findings

Answer: B — notify the provider immediately; pneumothorax is suspected

Rationale: Sudden dyspnea, decreased breath sounds on the ipsilateral side, and falling SpO2 following thoracentesis are the classic presentation of post-procedure pneumothorax — the most significant complication of thoracentesis. The nurse must notify the provider immediately for urgent evaluation and chest X-ray. Supplemental oxygen should be applied, but notification and evaluation take priority over documentation or repositioning. If tension pneumothorax is suspected (tracheal deviation, hemodynamic instability), this is a medical emergency requiring immediate intervention.


Question 6

During post-thoracentesis monitoring, the nurse notes the drained fluid volume was 1,800 mL. The patient now has a new cough, frothy sputum, and worsening dyspnea despite improved breath sounds bilaterally. What complication should the nurse suspect?

A) Recurrent pleural effusion B) Pulmonary embolism C) Reexpansion pulmonary edema D) Empyema

Answer: C — reexpansion pulmonary edema

Rationale: Reexpansion pulmonary edema is a rare but serious complication that can occur when more than 1,500 mL is drained per session or when a chronically collapsed lung reexpands rapidly. As the lung reexpands, fluid shifts into the newly opened alveolar spaces, causing non-cardiogenic pulmonary edema. Signs include cough, frothy or pink-tinged sputum, and worsening hypoxemia after drainage — paradoxically worsening despite the effusion being drained. This is why 1,500 mL is the recommended limit per thoracentesis session.



This article is for educational purposes. Always apply clinical judgment and follow your institution’s evidence-based protocols when caring for patients with pleural effusion.